Posters
« Back
Altering microRNA miR-15a/16 Levels as Potential Therapy in CLL: Extrapolating from the de novo NZB Mouse Model
EP20639
Poster Title: Altering microRNA miR-15a/16 Levels as Potential Therapy in CLL: Extrapolating from the de novo NZB Mouse Model
Submitted on 20 Dec 2013
Author(s): Kasar S, Salerno E, Underbayev C, Vollenweider D, Yuan Y and Raveche E
Affiliations: University of Medicine and Dentistry of New Jersey
Poster Views: 915
View poster »


Poster Information
Abstract: Expression of miR15a/16-1 was increased using lentiviral delivery (in vitro and in vivo) or by BSAP knockdown to inhibit B-CLL malignancy.
Summary: Altering microRNA miR-15a/16 Levels as Potential Therapy in CLL: Extrapolating from the de novo NZB Mouse Model
Report abuse »
Creative Commons

Related Posters


Delivery of RNP complexes for CRISPRi (dCas9) silencing in vitro and in vivo using crystalline ultrasmall particles (CUSP)
GM Unger*, VL Korman, BT Kren, DL Tobolt

Genetic Engineering in Male Sterility for Hybrid Variety Development
Abir Hasan Joy

Platinum™ II Taq Hot-Start DNA Polymerase: PCR simplified with universal annealing
Skaistė Valinskytė, Edita Elijošiūtė, Tomas Radzvilavičius, Miglė Mikutėnaitė, Jonas Belevičius, Aistė Serapinaitė, Rasa Sukackaitė

Single-use technology in the production of DNA-free Taq DNA polymerase
Kęstutis Bargaila, Vytautas, Budrys, Andrius Krasauskas, Dovilė Lisauskienė, Milda Romeikaitė, Sonata J.-Urbanavičienė, and Juozas Šiurkus

Lyo-ready SuperScript Reverse Transcriptases: High-Performance Lyophilization-Compatible Enzymes for RT-PCR-based assays
Inga Šerėnaitė, Darius Kavaliauskas, Monika Raižytė, Viktorija Urbonė, Gitana Timofejevaitė, Andrejus Naumovas, Juozas Šiurkus. Thermo Fisher Scientific Baltics UAB, V. A. Graičiūno 8, Vilnius, Lithuania